RemediumOne was involved in four Immunology clinical trials. Phase II and phase III studies were among the trials conducted.
January 15, 2020
Complex Rheumatoid Arthritis Phase IIb trial
We partnered with a global clinical research organisation to conduct a complex phase IIb, 12 week Randomized, double blind, Parallel group, Placebo-Controlled study to evaluate efficacy, safety and tolerability of different dosage regimens of IMP […]READ MORE